Beroseren

Beroseren is a medicine authorised by Swissmedic under authorisation number 69715. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Herbal medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 04 April 2025 and the authorisation is limited until 03 April 2030. ATC code N05C places the medicine in the group Psycholeptics.

Dispensing category D
Authorisation number 69715
ATC N05C
Herbal medicines

Authorisation data
Authorisation number	69715
Name	Beroseren
Full name	Beroseren, überzogene Tablette
Authorisation holder	Bayer (Schweiz) AG
Medicinal product code	Herbal medicines
Dispensing category	D · No prescription, with advice
ATC code	N05C
First authorisation	04 April 2025
Authorisation validity	03 April 2030

Strengths
No.	Name	Dispensing category	Authorisation date
1	Beroseren, überzogene Tablette	D	04 April 2025

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	40	Tablette(n)	N05C	01.04.1.	D
2	120	Tablette(n)	N05C	01.04.1.	D
3	180	Tablette(n)	N05C	01.04.1.	D

Scroll the table sideways

Other medicines from this authorisation holder

Adempas 0.5 mgAuthorisation number 62903 · ATC C02KX05B Adempas junior 0.15 mg/mlAuthorisation number 69929 · ATC C02KX05B AleveAuthorisation number 53810 · ATC M01AE02D Alka-SeltzerAuthorisation number 8671 · ATC N02BA01D Ambelvist 0.1 mmol/ mlAuthorisation number 70405 · ATC V08CA13B Ambelvist 0.1 mmol/ mlAuthorisation number 70441 · ATC V08CA13B Ambelvist 0.1 mmol/ nlAuthorisation number 70440 · ATC V08CA13B AngeliqAuthorisation number 56275 · ATC G03FA17B

Frequently asked questions

Is Beroseren authorised in Switzerland?

Yes. Beroseren is authorised by Swissmedic under authorisation number 69715, data as of 01 September 2026. The authorisation is limited until 03 April 2030.

Which dispensing category does Beroseren have?

Beroseren is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Beroseren?

The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.